Table 3.
Characteristics of Filler Use (n=65)
| N (%) | |
|---|---|
| Injection frequency | |
| 1 | 19 (29.2) |
| 2–4 | 23 (35.4) |
| 5–9 | 17 (26.2) |
| More than 10 | 6 (9.2) |
| Substance injected | |
| Silicone | 55 (84.6) |
| Mineral oil | 5 (7.7) |
| Biopolymer | 2 (3.1) |
| Collagen | 1 (1.5) |
| Other | 5 (7.7) |
| Most recent provider viewed as medical professional | |
| Yes | 28 (43.1) |
| No | 36 (55.4) |
| Don't know | 1 (1.5) |
| Any physical complication | |
| Yes | 51 (78.5) |
| No | 14 (21.5) |
| No. of complications | |
| 0 | 14 (22.7) |
| 1–2 | 17 (25.8) |
| 3–5 | 17 (25.8) |
| 6–9 | 9 (13.6) |
| 10+ | 8 (12.1) |
| Physical complication | |
| Pain at the injection site | 28 (43.1) |
| Swelling | 28 (43.1) |
| Hematoma | 26 (40.0) |
| Erythema/redness | 24 (36.9) |
| Migration/change in shape | 24 (36.9) |
| Hypersensitivity reactions | 18 (27.7) |
| Hardened skin (induration) | 14 (21.5) |
| Itchy skin | 14 (21.5) |
| Numbness/loss of feeling | 13 (20.0) |
| Fever | 10 (15.4) |
| Cellulitis | 10 (15.4) |
| Granuloma formation | 9 (13.8) |
| Rejection of foreign body | 8 (12.3) |
| Bleeding | 8 (12.3) |
| Nausea or vomiting | 7 (10.8) |
| Rash | 6 (9.2) |
| Weight loss | 2 (3.1) |
| Pulmonary embolism | 2 (3.1) |
| Ulceration | 1 (1.5) |
| Other | 4 (6.2) |